These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30400617)

  • 21. Nonclinical pharmacokinetics of BMS-292655, a water-soluble prodrug of the antifungal ravuconazole.
    Knipe JO; Mosure KW
    Biopharm Drug Dispos; 2008 Jul; 29(5):270-9. PubMed ID: 18548464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical disposition of GDC-0973 and prospective and retrospective analysis of human dose and efficacy predictions.
    Choo EF; Belvin M; Boggs J; Deng Y; Hoeflich KP; Ly J; Merchant M; Orr C; Plise E; Robarge K; Martini JF; Kassees R; Aoyama RG; Ramaiya A; Johnston SH
    Drug Metab Dispos; 2012 May; 40(5):919-27. PubMed ID: 22315332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel prodrug approach for tertiary amines. 3. In vivo evaluation of two N-phosphonooxymethyl prodrugs in rats and dogs.
    Krise JP; Charman WN; Charman SA; Stella VJ
    J Pharm Sci; 1999 Sep; 88(9):928-32. PubMed ID: 10479356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and metabolism of the prodrug DB289 (2,5-bis[4-(N-methoxyamidino)phenyl]furan monomaleate) in rat and monkey and its conversion to the antiprotozoal/antifungal drug DB75 (2,5-bis(4-guanylphenyl)furan dihydrochloride).
    Midgley I; Fitzpatrick K; Taylor LM; Houchen TL; Henderson SJ; Wright SJ; Cybulski ZR; John BA; McBurney A; Boykin DW; Trendler KL
    Drug Metab Dispos; 2007 Jun; 35(6):955-67. PubMed ID: 17360833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil(®)): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues.
    Amitay Y; Shmeeda H; Patil Y; Gorin J; Tzemach D; Mak L; Ohana P; Gabizon A
    Pharm Res; 2016 Mar; 33(3):686-700. PubMed ID: 26572644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of metabolite kinetics by deconvolution and in vivo-in vitro correlations of metabolite formation rates: studies of fibrinogen receptor antagonist ester prodrugs.
    Prueksaritanont T; Gorham LM; Yeh KC
    J Pharm Sci; 1997 Dec; 86(12):1345-51. PubMed ID: 9423143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of tebipenem pivoxil, a novel oral carbapenem antibiotic, in experimental animals].
    Kijima K; Morita J; Suzuki K; Aoki M; Kato K; Hayashi H; Shibasaki S; Kurosawa T
    Jpn J Antibiot; 2009 Jun; 62(3):214-40. PubMed ID: 19882982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of a potent tubulin polymerization inhibitor: synthesis and evaluation of water-soluble prodrugs of benzophenone analog.
    Lee J; Bae S; Lee SH; Choi H; Kim YH; Kim SJ; Park GT; Moon SK; Kim DH; Lee S; Ahn SK; Choi NS; Lee KJ
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6327-30. PubMed ID: 20850313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism, pharmacokinetics, tissue distribution, and stability studies of the prodrug analog of an anti-hepatitis B virus dinucleoside phosphorothioate.
    Coughlin JE; Pandey RK; Padmanabhan S; O'Loughlin KG; Marquis J; Green CE; Mirsalis JC; Iyer RP
    Drug Metab Dispos; 2012 May; 40(5):970-81. PubMed ID: 22328581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.
    Prueksaritanont T; Gorham LM; Ellis JD; Fernandez-Metzler C; Deluna P; Gehret JR; Strong KL; Hochman JH; Askew BC; Duggan ME; Gilbert JD; Lin JH; Vyas KP
    Drug Metab Dispos; 1996 Nov; 24(11):1263-71. PubMed ID: 8937862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs.
    Yang JZ; Chen W; Borchardt RT
    J Pharmacol Exp Ther; 2002 Nov; 303(2):840-8. PubMed ID: 12388671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Species differences in liver accumulation and metabolism of nucleotide prodrug sofosbuvir.
    Wang T; Babusis D; Park Y; Niu C; Kim C; Zhao X; Lu B; Ma B; Muench RC; Sperger D; Ray AS; Murakami E
    Drug Metab Pharmacokinet; 2020 Jun; 35(3):334-340. PubMed ID: 32345577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C118P exerted potent anti-tumor effects against melanoma with induction of G2/M arrest via inhibiting the expression of BUB1B.
    Ren K; Zhou M; Li L; Wang C; Yuan S; Li H
    J Dermatol Sci; 2022 Nov; 108(2):58-67. PubMed ID: 36424293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic characterization of 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone, a novel 11β-hydroxysteroid dehydrogenase type 1 inhibitor in rats.
    Zheng Z; Seo H; Kwak HJ; Kim KY; Ahn JH; Bae MA; Song JS
    Arch Pharm Res; 2016 Apr; 39(4):492-498. PubMed ID: 26780247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits.
    Groll AH; Mickiene D; Petraitis V; Petraitiene R; Kelaher A; Sarafandi A; Wuerthwein G; Bacher J; Walsh TJ
    J Antimicrob Chemother; 2005 Nov; 56(5):899-907. PubMed ID: 16172108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of Curcumin Diethyl Disuccinate, a Prodrug of Curcumin, in Wistar Rats.
    Bangphumi K; Kittiviriyakul C; Towiwat P; Rojsitthisak P; Khemawoot P
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):777-785. PubMed ID: 26563392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics, metabolism, and excretion of the intestinal peptide transporter 1 (SLC15A1)-targeted prodrug (1S,2S,5R,6S)-2-[(2'S)-(2-amino)propionyl]aminobicyclo[3.1.0.]hexen-2,6-dicarboxylic acid (LY544344) in rats and dogs: assessment of first-pass bioactivation and dose linearity.
    Perkins EJ; Abraham T
    Drug Metab Dispos; 2007 Oct; 35(10):1903-9. PubMed ID: 17646281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, biological evaluation, and pharmacokinetic study of novel liguzinediol prodrugs.
    Liu Z; Li W; Wen HM; Bian HM; Zhang J; Chen L; Chen L; Yang KD
    Molecules; 2013 Apr; 18(4):4561-72. PubMed ID: 23599014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism and pharmacokinetics of JM6 in mice: JM6 is not a prodrug for Ro-61-8048.
    Beconi MG; Yates D; Lyons K; Matthews K; Clifton S; Mead T; Prime M; Winkler D; O'Connell C; Walter D; Toledo-Sherman L; Munoz-Sanjuan I; Dominguez C
    Drug Metab Dispos; 2012 Dec; 40(12):2297-306. PubMed ID: 22942319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.